Skip to main content
Log in

Hepatitis B virus DNA polymerase activity and hepatitis B e antigen (HBeAg)/anti-HBe status among type B chronic liver diseases

  • Original Article
  • Published:
Gastroenterologia Japonica Aims and scope Submit manuscript

Summary

To investigate the relationship between hepatitis B virus (HBV) replication and chronic liver disease, age-specific prevalences of HBeAg, anti-HBe, and HBV DNA polymerase (DNAP) activity were studied in 295 asymptomatic HBV carriers and 183 patients with B-type chronic liver diseases. DNAP activity decreased with age, and there was no difference in the overall prevalence of DNAP activity between the asymptomatic carriers (27.8%) and the chronic liver disease patients (27.3%). The prevalence of DNAP activity in the 40-and-over age group was significantly higher for the chronic liver disease patients (17.5%) than for the asymptomatic carriers (1.7%). The prevalence of HBeAg in the 40- and-over age group was also significantly higher for the chronic liver disease patients (33.8%) than for the asymptomatic carriers (2.6%). These data suggest that viral replication decreased with age and that viral replication occurring in older persons closely related to chronic liver disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Nordenfelt E, Kjellen L: Dane particles and e antigen in two different categories of hepatitis B antigen carriers. Intervirology 1975; 5: 225–232

    Article  PubMed  CAS  Google Scholar 

  2. Hindman SH, Gravelle CR, Murohy BL, et al: “e” antigen, Dane particles and serum DNA polymerase activity in HBsAg carriers. Ann Intern Med 1975; 85: 458–469

    Google Scholar 

  3. Imai M, Tachibana F, Moritsugu Y: Hepatitis B antigenassociated deoxyribonucleic acid polymerase activity and e antigen/anti-e system. Infect Immun 1976; 14: 631–635

    PubMed  CAS  Google Scholar 

  4. Tong MJ, Stevenson D, Gordon I: Correlation of e antigen, DNA polymerase activity, and Dane particles in chronic benign and chronic active type B hepatitis infections. J Infect Dis 1977; 135: 980–984

    PubMed  CAS  Google Scholar 

  5. Perrillp R, Campbell C, Wellinghoff W, et al: The relationship of hepatitis B e antigen, DNA polymerase activity, and titer of hepatitis B surface antigen with ongoing liver injury in chronic hepatitis B virus infection. Am J Gastroenterol 1982; 77: 445–449

    Google Scholar 

  6. Nordenfelt E, Andren-Sandberg M: Dane particle-associated DNA polymerase and e antigen: relation to chronic hepatitis among carriers of hepatitis B surface antigen. J Infect Dis 1976;134:85–89

    PubMed  CAS  Google Scholar 

  7. Hoofnagel JH, Dusheiko GM, Seef LB, et al: Seroconversion from hepatitis B e antigen to antibody in chronic type B hepatitis. Ann Intern Med 1981; 94: 744–748

    Google Scholar 

  8. Realdi G, Alberti A, Ruggi M, et al: Seroconversion from hepatitis B e antigen to anti-HBe in chronic hepatitis B virus infection. Gastroenterology 1980; 79: 195–199

    PubMed  CAS  Google Scholar 

  9. Ettigner RB, Tong MJ, Landing BH, et al: Hepatitis B infection in pediatric dialysis and transplant patients: Significant of e antigen. J Pediatr 1980; 97: 550–553

    Article  Google Scholar 

  10. Alberti A, Tremolada F, Fattovich G, et al: Virus replication and liver disease in chronic hepatitis B virus infection. Dig Dis Sci 1983; 28: 962–966

    Article  Google Scholar 

  11. Kashiwagi S, Hayashi J, Ikematsu H, et al: An epidemiologic study of hepatitis B virus in Okinawa and Kyushu, Japan. Am J Epidemiol 1983; 118: 787–794

    PubMed  CAS  Google Scholar 

  12. Kaplan PM, Greenman RL, Gerin JL, et al: DNA-associated with human hepatitis B antigen. J Virol 1973; 12: 995–1005

    PubMed  CAS  Google Scholar 

  13. Barker LF, Chisari FV, McGrath PP, et al: Transmission of type B viral hepatitis to chimpanzees. J Infect Dis 1973;127: 648–662

    PubMed  CAS  Google Scholar 

  14. Dudely FJ, Fox RA, Sherloch S: Cellular immunity and hepatitis associated Australia antigen in liver disease. Lancet 1972; 1: 723–736

    Article  Google Scholar 

  15. Eddelstone ALWF, Williams R: Inadequate antibody response to HBsAg or suppressor T cell defect in development of active chronic hepatitis. Lancet 1974; 2: 1543–1545

    Article  Google Scholar 

  16. Edington TS, Chisari FV: Immunological aspects of hepatitis B virus infection. Am J Med Sci 1975; 270: 213–227

    Article  Google Scholar 

  17. Davis GL, Hoofnagel JH, Waggoner JG: Spontaneous reactivation of chronic hepatitis B virus infection. Gastroenterology 1984;86:23–235.

    Google Scholar 

  18. Kashiwagi S, Hayashi J, Ikematsu H, et al: Transmission of hepatitis B virus among siblings. Am J Epidemiol 1984; 120: 617–625

    PubMed  CAS  Google Scholar 

  19. Stevens CE, Beasley RP, Tsai J, et al: Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med 1975; 292: 771–774

    Article  PubMed  CAS  Google Scholar 

  20. Beasly RP, Hwang LY, Lin CC, et al: Incidence of hepatitis B virus infection in preschool children in Taiwan. J Infect Dis 1982; 146: 198–204

    Google Scholar 

  21. Miyakawa Y, Mayumi M: Characteriazation and clinical significance of HBeAg. In: Vyas GM, Cohn SN, Schmid R, eds. Viral hepatitis, Franklin institutes Press. Philadelphia, 1978;139–201

    Google Scholar 

  22. Andres LI, Sawhney VK, Scullard GH, et al: Dane particle DNA polymerase and HBeAg: Impact on clinical, laboratory and histological findings in hepatitis B associated chronic liver disease. Hepatology 1981; 1: 583–585

    Article  PubMed  CAS  Google Scholar 

  23. Sagnelli E, Manzillo G, Maio G, et al: Serum levels of hepatitis B surface and core antigen during immunosupressive treatment of HBsAg-positive chronic active hepatitis. Lancet 1980;2:395–397

    Article  PubMed  CAS  Google Scholar 

  24. Bianchi L, Gudat F: Immunopathology of hepatitis B. In: Popper H, Schaffner F, eds. Progress in liver diseases. Vol 6. Grune and Stratton, New York. 1979; 371–392

    Google Scholar 

  25. Sun SC, Beasly RP, Anderson KE, et al: Serial liver biopsy observations in hepatitis B antigen carriers by light and electron microscopy. Am J Dig Dis 1976;21:336–369

    Article  Google Scholar 

  26. Sampliner RE, Hamilton FA, Iseri OA, et al: Liver histology and frequency of clearance of the hepatitis B surface antigen (HBsAg) in chronic carriers. Am J Med Sci 1979;277:17–22

    Article  PubMed  CAS  Google Scholar 

  27. Chen DS, Sung JL, Lai MY: Hepatitis B e antigen antibody in chronic liver diseases and hepatocellular carcinoma. Hepatogastroenterol 1981; 28: 288–291

    CAS  Google Scholar 

  28. Liaw YH, Chu CM, Lin DY, et al: Age-specific prevalence and significance of hepatitis B e antigen and antibody in chronic hepatitis B virus infection in Taiwan: A comparison among asymptomatic carries, chronic hepatitis, liver cirrhosis, and hepatocelluar carcinoma. J Med Virol 1984; 13: 385–391

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kashiwagi, S., Hayashi, J., Ikematsu, H. et al. Hepatitis B virus DNA polymerase activity and hepatitis B e antigen (HBeAg)/anti-HBe status among type B chronic liver diseases. Gastroenterol Jpn 23, 117–123 (1988). https://doi.org/10.1007/BF02799022

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02799022

Key Words

Navigation